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The number of mutations in mitochondrial DNA (mtDNA) thought
to causemetabolic disorders in patients is growing. At present, we lack
the technology to introduce these mutations into the mtDNA of model
organisms for detailed study. In this study, random mtDNA mutations
were generated using the transgenic mtDNA mutator mouse, which
expresses an engineered mitochondrial polymerase defective in its
proofreading function. Female lines were then established to transmit
and segregate the resulting mutations. We observed the selective loss
of nonsense mutations in the protein coding genes, consistent with
strong purifying selection by the female germline. The selection was
evident two generations after the founder mtDNA mutator mouse,
eliminating these nonsense mutations before they were detectable by
Sanger sequencing methods. Curiously, the tRNA and rRNA genes do
not show the same rapid selection against mutations despite strong
evolutionary sequence conservation. Despite this purifying selection,
putative deleterious mutations were identiﬁed and propagated in the
mouse lines. Also, mutations analogous to human pathogenic mtDNA
mutations were identiﬁed. These results will aid in the generation of
more accurate models of inheritance of disease-causing mtDNA
mutations and allow for the generation of laboratory mouse models
of mtDNA mutations known in human disease.
doi:10.1016/j.bbabio.2008.05.313
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The aim of this study was to investigate the adaptation of cancer
cells to low glucose conditions, as regard to their mitochondrial
features. To mimick glucose deprivation we used the glutamine/
galactose medium. We chose a model of human breast carcinoma
(HTB-126) and control (HTB-125) cultured cells, as nearly 40% of breast
malignancies exhibit hypoxic tumour regions with low oxygen
concentrations (pO2b2 mmHg) and poor glucose delivery. In these
cells wemeasured the sensitivity ofmitochondria towards a decrease in
oxygen concentration by high resolution respirometry. This can be
quantiﬁed by the p50 value, i.e the oxygen concentration at half-
maximal respiration in intact cells. In cancer cells, glucose deprivation
lead to a change in this apparent afﬁnity for oxygen, as p50 values
decreased from 0.62±0.13 µM (glucose) to 0.46±0.11 µMO2 (galactose).
There was also a 2 to 3-fold increase in routine respiration in glucose
versus galactose medium, both in control and cancer cells, respectively.
Mitochondrial networkmorphology also presented typical adaptations.
These results suggest that in absence of glucose, as can occur in solid
tumors, mitochondria are enhanced to produce the vital ATP.
doi:10.1016/j.bbabio.2008.05.314
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Leber's hereditary optic neuropathy (LHON) constitutes the most
frequent mitochondrial disorder. Over 90% of LHON cases are due to
three point mutations in the mitochondrial ND1, ND4 and ND6
complex I genes. However, the functional effects of these mutations
on complex I remain unsolved. By using blue native gel electrophor-
esis, we have studied complex I assembly in cybrids harbouring the
three most common LHON mutations under different mitochondrial
haplotypes. No decrease in complex I activity or in the steady-state
levels of respiratory chain complexes was detected in the mutant
cybrids. However, an accumulation of low molecular weight
subcomplexes suggested an assembly or stability defect in the
mutants. To check the assembly kinetics of respiratory chain
complexes, cells were incubated for six days in the presence of a
reversible inhibitor of mitochondrial translation, doxycicline. After
this time the drug was released from the medium, which let
assembly resume. Our results show delayed kinetics of complex I
assembly and late recovery of complex I activity in all LHON cybrids
compared to controls. Differences amongst cybrids carrying the same
mutation under different haplogroups were observed. These results
will provide essential information about the nature of complex I
deﬁciencies and will enhance our understanding of LHON disease
mechanisms.
doi:10.1016/j.bbabio.2008.05.315
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Heart failure (HF) is a consequence of progressive deterioration of
cardiac function. Little information is available on mitochondrial
dysfunction in failing human hearts. We evaluated cardiac mitochon-
drial respiration in small biopsies from patients ranging from healthy
donors to advanced stage of HF (dilated cardiomyopathy, during
transplantation). Coupled OXPHOS capacity and uncoupled respira-
tion (capacity of the electron transport system; ETS) were measured
by high-resolution respirometry in permeabilized ﬁbres (left and
right ventricle, atrial appendage). ADP-stimulated ﬂux through
Complex I was only 0.4 of uncoupled respiration, indicating a strong
limitation by the phosphorylation system. ETS capacity was higher
with NADH-related substrates and succinate, supporting convergent
electron input through Complexes I and II simultaneously into the Q-
cycle. The additive effect of succinate was higher in patients with
advanced stage of HF compared to donor hearts. HF mitochondria
were tightly coupled, as evaluated by respiratory control in the
absence of ADP. Fibres from atrial appendage showed lower
respiratory ﬂuxes with all substrate combinations compared to left
and right ventricle. Respiratory control patterns (ﬂux ratios for
speciﬁc substrates relative to ETS capacity with convergent electron)
were similar in the three tissues, but signiﬁcantly different compared
to the rodent heart. This study provides a basis for characterization of
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